Cliff Asness’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $86.9M | Sell |
695,432
-469,371
| -40% | -$61.8M | 0.03% | 648 |
|
|
2026
Q1 | $162M | Sell |
1,164,803
-1,530,141
| -57% | -$214M | 0.07% | 354 |
|
|
2025
Q4 | $331M | Buy |
2,694,944
+315,398
| +13% | +$38.3M | 0.17% | 135 |
|
|
2025
Q3 | $264M | Sell |
2,379,546
-91,292
| -4% | -$10.4M | 0.17% | 149 |
|
|
2025
Q2 | $272M | Buy |
2,470,838
+606,168
| +33% | +$64.5M | 0.23% | 96 |
|
|
2025
Q1 | $207M | Buy |
1,864,670
+51,116
| +3% | +$5.27M | 0.21% | 107 |
|
|
2024
Q4 | $168M | Sell |
1,813,554
-129,518
| -7% | -$11.7M | 0.22% | 101 |
|
|
2024
Q3 | $163M | Sell |
1,943,072
-110,001
| -5% | -$8.39M | 0.22% | 95 |
|
|
2024
Q2 | $141M | Sell |
2,053,073
-1,261,631
| -38% | -$84.2M | 0.22% | 106 |
|
|
2024
Q1 | $243M | Sell |
3,314,704
-549,472
| -14% | -$42.3M | 0.41% | 38 |
|
|
2023
Q4 | $313M | Sell |
3,864,176
-909,512
| -19% | -$70.8M | 0.59% | 20 |
|
|
2023
Q3 | $358M | Buy |
4,773,688
+531,314
| +13% | +$40.9M | 0.74% | 12 |
|
|
2023
Q2 | $325M | Buy |
4,242,374
+731,362
| +21% | +$58.3M | 0.69% | 14 |
|
|
2023
Q1 | $287M | Sell |
3,511,012
-259,147
| -7% | -$21.5M | 0.63% | 19 |
|
|
2022
Q4 | $322M | Sell |
3,770,159
-1,743,093
| -32% | -$138M | 0.73% | 15 |
|
|
2022
Q3 | $340M | Sell |
5,513,252
-582,541
| -10% | -$36.7M | 0.83% | 11 |
|
|
2022
Q2 | $376M | Buy |
6,095,793
+3,383,767
| +125% | +$209M | 0.85% | 8 |
|
|
2022
Q1 | $161M | Buy |
2,712,026
+1,482,141
| +121% | +$94.7M | 0.31% | 62 |
|
|
2021
Q4 | $89.3M | Buy |
1,229,885
+92,279
| +8% | +$6.36M | 0.16% | 144 |
|
|
2021
Q3 | $79.5M | Sell |
1,137,606
-18,824
| -2% | -$1.32M | 0.15% | 163 |
|
|
2021
Q2 | $79M | Sell |
1,156,430
-814,483
| -41% | -$54.4M | 0.14% | 175 |
|
|
2021
Q1 | $127M | Sell |
1,970,913
-1,000,300
| -34% | -$64.5M | 0.21% | 115 |
|
|
2020
Q4 | $169M | Sell |
2,971,213
-786,288
| -21% | -$47.4M | 0.3% | 70 |
|
|
2020
Q3 | $235M | Sell |
3,757,501
-903,477
| -19% | -$62.7M | 0.4% | 48 |
|
|
2020
Q2 | $353M | Sell |
4,660,978
-1,136,461
| -20% | -$87.1M | 0.57% | 25 |
|
|
2020
Q1 | $433M | Sell |
5,797,439
-1,411,277
| -20% | -$97.5M | 0.73% | 18 |
|
|
2019
Q4 | $465M | Buy |
7,208,716
+2,682,046
| +59% | +$175M | 0.53% | 33 |
|
|
2019
Q3 | $287M | Sell |
4,526,670
-891,623
| -16% | -$58.3M | 0.34% | 77 |
|
|
2019
Q2 | $363M | Sell |
5,418,293
-3,538,186
| -40% | -$233M | 0.41% | 49 |
|
|
2019
Q1 | $582M | Buy |
8,956,479
+285,954
| +3% | +$19M | 0.62% | 22 |
|
|
2018
Q4 | $542M | Buy |
8,670,525
+326,298
| +4% | +$22.8M | 0.63% | 29 |
|
|
2018
Q3 | $644M | Sell |
8,344,227
-545,884
| -6% | -$41.2M | 0.62% | 31 |
|
|
2018
Q2 | $630M | Sell |
8,890,111
-1,763,758
| -17% | -$125M | 0.63% | 28 |
|
|
2018
Q1 | $803M | Sell |
10,653,869
-1,978,920
| -16% | -$157M | 0.87% | 11 |
|
|
2017
Q4 | $905M | Buy |
12,632,789
+516,486
| +4% | +$39.2M | 0.95% | 6 |
|
|
2017
Q3 | $982M | Buy |
12,116,303
+3,384,623
| +39% | +$259M | 1.17% | 3 |
|
|
2017
Q2 | $618M | Buy |
8,731,680
+3,518,634
| +67% | +$234M | 0.82% | 8 |
|
|
2017
Q1 | $354M | Buy |
5,213,046
+1,066,172
| +26% | +$75M | 0.47% | 38 |
|
|
2016
Q4 | $297M | Sell |
4,146,874
-13,985
| -0.3% | -$1.04M | 0.41% | 52 |
|
|
2016
Q3 | $329M | Buy |
4,160,859
+1,310,117
| +46% | +$106M | 0.5% | 30 |
|
|
2016
Q2 | $238M | Sell |
2,850,742
-140,407
| -5% | -$12.5M | 0.42% | 44 |
|
|
2016
Q1 | $275M | Sell |
2,991,149
-977,184
| -25% | -$88.1M | 0.49% | 30 |
|
|
2015
Q4 | $402M | Sell |
3,968,333
-800,138
| -17% | -$83.3M | 0.7% | 12 |
|
|
2015
Q3 | $468M | Buy |
4,768,471
+586,783
| +14% | +$65.2M | 0.94% | 5 |
|
|
2015
Q2 | $490M | Buy |
4,181,688
+67,030
| +2% | +$7.32M | 0.97% | 5 |
|
|
2015
Q1 | $404M | Sell |
4,114,658
-716,746
| -15% | -$72.8M | 0.92% | 6 |
|
|
2014
Q4 | $455M | Buy |
4,831,404
+2,569,921
| +114% | +$266M | 0.95% | 3 |
|
|
2014
Q3 | $241M | Buy |
2,261,483
+1,292,298
| +133% | +$127M | 0.66% | 16 |
|
|
2014
Q2 | $80.4M | Sell |
969,185
-388,000
| -29% | -$30.2M | 0.22% | 122 |
|
|
2014
Q1 | $96.2M | Buy |
1,357,185
+439,427
| +48% | +$34.5M | 0.29% | 77 |
|
|
2013
Q4 | $69M | Buy |
917,758
+447,607
| +95% | +$31.2M | 0.21% | 126 |
|
|
2013
Q3 | $29.5M | Sell |
470,151
-143,586
| -23% | -$8.58M | 0.1% | 246 |
|
|
2013
Q2 | $31.4M | Buy |
+613,737
| New | +$32M | 0.11% | 234 |
|
Other funds holding GILD
Cliff Asness's GILD Position: Q2 2026 in Review
Cliff Asness reduced its Gilead Sciences (GILD) stake by 40% in Q2 2026, selling an estimated $61.8M and leaving 695,432 shares worth $86.9M. The position accounts for 0.03% of the portfolio, ranked #648.
Cliff Asness first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $982M in Q3 2017. 2,265 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Cliff Asness held 695,432 shares of Gilead Sciences worth $86.9M as of Q2 2026.
- Cliff Asness sold 469,371 Gilead Sciences shares in Q2 2026, an estimated $61.8M.
- Gilead Sciences made up 0.03% of Cliff Asness's portfolio in Q2 2026, its #648 holding.
- Cliff Asness first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Cliff Asness's Gilead Sciences position peaked at $982M in Q3 2017.
- 2,265 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.